Viewing Study NCT01106651


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2026-01-10 @ 3:02 PM
Study NCT ID: NCT01106651
Status: COMPLETED
Last Update Posted: 2014-11-04
First Post: 2010-04-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus
Sponsor: Janssen Research & Development, LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR017014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators